Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/21/2022
Closing price: 68.51
|Support price level:||$65.08|
|Resistance price level:||$70.78|
|Relative strength index (14-day RSI)||23.4|
- The price of this low-beta stock is expected to increase by 0.26% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.
- Price crossed below 50-day moving average this week - a bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 6.2% in the next week.
- 14.2% in the next month.
- 47.2% in the next year.